Sirtris Pharmaceuticals

About:

Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.

Website: http://www.sirtrispharma.com

Top Investors: Hercules Capital, Bessemer Venture Partners, Wellcome Trust, Polaris Partners, Alexandria Real Estate Equities

Description:

[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)

Total Funding Amount:

$82M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)sirtrispharma.com

Founders:

David Sinclair, Kevin Bitterman, Paul Schimmel, Richard Aldrich

Number of Employees:

51-100

Last Funding Date:

2006-04-20

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai